Cite

HARVARD Citation

    Kilian, M. et al. (2021). OS12.4.A MHC class II-restricted transgenic T cell receptor therapy targeting mutant capicua transcriptional repressor in experimental gliomas. Neuro-oncology. p. ii15. [Online]. 
  
Back to record